Velocity’s Spartanburg research site was founded in 2004 as the original research site of VitaLink Research, and acquired by Velocity in 2021. This site’s initial focus was on clinical trials related to Respiratory and Women’s Health. Over the years, our Spartanburg site has also gained expertise in vaccine, infectious disease, and NASH trials. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP.
Located off a major a highway, Spartanburg is next door to the Principal Investigator’s pulmonary practice. The site is over 10,000 square feet featuring 10 exam rooms and a 15 bed overnight patient area as well as ample parking for patients. The local hospital is located 2 miles away. The Spartanburg team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.